Objective: To evaluate the GORE® Cardioform ASD Occluder (GCA)(WL Gore & Associates) device for closure of ostium secundum atrial septal defects (ASDs) with predicted indication for surgical correction.

Background: Closure of large ASD in small children by transcatheter approach is still challenging. This study evaluated the results of GCA in this subset of patients in a tertiary referral center.

Methods: Between January 2020 and March 2022, 97 children underwent transcatheter ASD closure at our Institution. Of them, 38 had a large defect (diameter/weight > 1.2 or diameter/body surface area > 20 mm/m ), predicted suitable for surgery and underwent closure with GCA. Procedure results and midterm outcome are reported.

Results: Patients' age and weight were 5.5 ± 1.5 years and 19.7 ± 4.7 kg, respectively. Absolute and relative ASD size was 21.5 ± 3.6 mm, 1.1 ± 0.2 mm/kg, and 27.7 ± 4.6 mm/m , respectively, resulting in QP/QS of 2.0 ± 0.8. Three patients were sent to surgery after balloon sizing. Four of the remaining 35 patients who underwent device deployment, needed rescue or elective surgery due to device embolization (n = 1), device instability (n = 2) or new-onset tricuspid valve regurgitation (n = 1). Procedure feasibility was 88.6%. Major complications were recorded in two patients (5.7%). Minor complications were recorded in five patients (14.3%). Complete closure at discharge was 90.3% (28/31 pts) rising to 100% at the last follow-up evaluation. Wireframe fracture rate at the 6 months examination was 52%, without clinical and instrumental consequences.

Conclusions: Percutaneous treatment with GCA device is effective and safe in a high percentage of ASD children with predicted indications for surgical correction.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocs.16786DOI Listing

Publication Analysis

Top Keywords

ostium secundum
8
secundum atrial
8
atrial septal
8
septal defects
8
gore® cardioform
8
cardioform asd
8
asd occluder
8
complications recorded
8
recorded patients
8
asd
6

Similar Publications

This case report explores the management of a 56-year-old female oncology patient presenting with acute ST-elevation myocardial infarction (STEMI) and an incidental atrial septal defect (ASD). The patient, with a history of rectal cancer and hypothyroidism, experienced acute chest pain and dyspnea. She was diagnosed with an inferior STEMI and underwent percutaneous coronary intervention (PCI) with the placement of three medicated stents in the right coronary artery.

View Article and Find Full Text PDF

Background: According to previous literature reports, PTPN11 gene variants account for approximately 50% of Noonan syndrome (NS) cases and 85% of Leopard syndrome (LS) cases. Several patients who were diagnosed with NS or LS complicated with Chiari I malformation (CIM) and/or syringomyelia have been reported to have a PTPN11 variant. However, it is not always clear whether the association between CIM and/or syringomyelia and PTPN11 variants is real or random.

View Article and Find Full Text PDF

Long-term prognosis of elderly patients undergoing atrial septal defect closure: Are we acting too late?

Curr Probl Cardiol

February 2025

Cardiovascular Intervention Unit, Hospital de Santa Cruz, ULSLO, Lisbon, Portugal; Pediatric Cardiology Department, Hospital de Santa Cruz, ULSLO, Lisbon, Portugal.

Article Synopsis
  • A study investigated the effects of closing atrial septal defects (ASD) on survival in patients aged 65 and older, noting that many cases are diagnosed late in life.
  • Out of 706 patients treated for ASD, 37 were seniors, with a significant portion experiencing heart failure and other complications.
  • The results indicated that while the overall survival rate was in line with expected life expectancy, a notable 46% of elderly patients died prematurely, with higher pulmonary artery pressure and severe tricuspid regurgitation linked to these early deaths.
View Article and Find Full Text PDF
Article Synopsis
  • - The 2q31 deletion is linked to a specific set of features including developmental delays, short stature, distinct facial traits (like microcephaly and ear deformities), and limb defects, identified in 38 patients so far.
  • - An 8-year-old girl with symptoms resembling velocardiofacial syndrome was diagnosed with a 2q31 microdeletion, confirmed through genetic testing that showed a non-continuous deletion between certain cytobands, along with treatment for her speech and swallowing difficulties.
  • - This case is the first recorded instance of a complex deletion in the 2q31 regions, enhancing knowledge about the conditions linked to these genetic changes, and highlights the importance of advanced diagnostic methods to distinguish it
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!